Sex differences in the evaluation and treatment of acute ischaemic stroke

Cheryl Bushnell, Virginia J. Howard, Lynda Lisabeth, Valeria Caso, Seana Gall, Dawn Kleindorfer, Seemant Chaturvedi, Tracy E. Madsen, Stacie L. Demel, Seung Jae Lee, Mathew Reeves

Research output: Contribution to journalReview article

5 Citations (Scopus)

Abstract

With the greater availability of treatments for acute ischaemic stroke, including advances in endovascular therapy, personalised assessment of patients before treatment is more important than ever. Women have a higher lifetime risk of stroke; therefore, reducing potential sex differences in the acute stroke setting is crucial for the provision of equitable and fast treatment. Evidence indicates sex differences in prevalence and types of non-traditional stroke symptoms or signs, prevalence of stroke mimics, and door-to-imaging times, but no substantial differences in use of emergency medical services, stroke knowledge, eligibility for or access to thrombolysis or thrombectomy, or outcomes after either therapy. Women presenting with stroke mimics or non-traditional stroke symptoms can be misdiagnosed, which can lead to inappropriate triage, and acute treatment delays. It is essential for health-care providers to recognise possible sex differences in stroke symptoms, signs, and mimics. Future studies focused on confounders that affect treatment and outcomes, such as age and pre-stroke function, are also needed.

Original languageEnglish (US)
Pages (from-to)641-650
Number of pages10
JournalThe Lancet Neurology
Volume17
Issue number7
DOIs
StatePublished - Jul 1 2018

Fingerprint

Sex Characteristics
Stroke
Therapeutics
Signs and Symptoms
Thrombectomy
Triage
Emergency Medical Services
Diagnostic Errors
Health Personnel

ASJC Scopus subject areas

  • Clinical Neurology

Cite this

Bushnell, C., Howard, V. J., Lisabeth, L., Caso, V., Gall, S., Kleindorfer, D., ... Reeves, M. (2018). Sex differences in the evaluation and treatment of acute ischaemic stroke. The Lancet Neurology, 17(7), 641-650. https://doi.org/10.1016/S1474-4422(18)30201-1

Sex differences in the evaluation and treatment of acute ischaemic stroke. / Bushnell, Cheryl; Howard, Virginia J.; Lisabeth, Lynda; Caso, Valeria; Gall, Seana; Kleindorfer, Dawn; Chaturvedi, Seemant; Madsen, Tracy E.; Demel, Stacie L.; Lee, Seung Jae; Reeves, Mathew.

In: The Lancet Neurology, Vol. 17, No. 7, 01.07.2018, p. 641-650.

Research output: Contribution to journalReview article

Bushnell, C, Howard, VJ, Lisabeth, L, Caso, V, Gall, S, Kleindorfer, D, Chaturvedi, S, Madsen, TE, Demel, SL, Lee, SJ & Reeves, M 2018, 'Sex differences in the evaluation and treatment of acute ischaemic stroke', The Lancet Neurology, vol. 17, no. 7, pp. 641-650. https://doi.org/10.1016/S1474-4422(18)30201-1
Bushnell C, Howard VJ, Lisabeth L, Caso V, Gall S, Kleindorfer D et al. Sex differences in the evaluation and treatment of acute ischaemic stroke. The Lancet Neurology. 2018 Jul 1;17(7):641-650. https://doi.org/10.1016/S1474-4422(18)30201-1
Bushnell, Cheryl ; Howard, Virginia J. ; Lisabeth, Lynda ; Caso, Valeria ; Gall, Seana ; Kleindorfer, Dawn ; Chaturvedi, Seemant ; Madsen, Tracy E. ; Demel, Stacie L. ; Lee, Seung Jae ; Reeves, Mathew. / Sex differences in the evaluation and treatment of acute ischaemic stroke. In: The Lancet Neurology. 2018 ; Vol. 17, No. 7. pp. 641-650.
@article{62379351606e4344ada1764a4061cc09,
title = "Sex differences in the evaluation and treatment of acute ischaemic stroke",
abstract = "With the greater availability of treatments for acute ischaemic stroke, including advances in endovascular therapy, personalised assessment of patients before treatment is more important than ever. Women have a higher lifetime risk of stroke; therefore, reducing potential sex differences in the acute stroke setting is crucial for the provision of equitable and fast treatment. Evidence indicates sex differences in prevalence and types of non-traditional stroke symptoms or signs, prevalence of stroke mimics, and door-to-imaging times, but no substantial differences in use of emergency medical services, stroke knowledge, eligibility for or access to thrombolysis or thrombectomy, or outcomes after either therapy. Women presenting with stroke mimics or non-traditional stroke symptoms can be misdiagnosed, which can lead to inappropriate triage, and acute treatment delays. It is essential for health-care providers to recognise possible sex differences in stroke symptoms, signs, and mimics. Future studies focused on confounders that affect treatment and outcomes, such as age and pre-stroke function, are also needed.",
author = "Cheryl Bushnell and Howard, {Virginia J.} and Lynda Lisabeth and Valeria Caso and Seana Gall and Dawn Kleindorfer and Seemant Chaturvedi and Madsen, {Tracy E.} and Demel, {Stacie L.} and Lee, {Seung Jae} and Mathew Reeves",
year = "2018",
month = "7",
day = "1",
doi = "10.1016/S1474-4422(18)30201-1",
language = "English (US)",
volume = "17",
pages = "641--650",
journal = "The Lancet Neurology",
issn = "1474-4422",
publisher = "Lancet Publishing Group",
number = "7",

}

TY - JOUR

T1 - Sex differences in the evaluation and treatment of acute ischaemic stroke

AU - Bushnell, Cheryl

AU - Howard, Virginia J.

AU - Lisabeth, Lynda

AU - Caso, Valeria

AU - Gall, Seana

AU - Kleindorfer, Dawn

AU - Chaturvedi, Seemant

AU - Madsen, Tracy E.

AU - Demel, Stacie L.

AU - Lee, Seung Jae

AU - Reeves, Mathew

PY - 2018/7/1

Y1 - 2018/7/1

N2 - With the greater availability of treatments for acute ischaemic stroke, including advances in endovascular therapy, personalised assessment of patients before treatment is more important than ever. Women have a higher lifetime risk of stroke; therefore, reducing potential sex differences in the acute stroke setting is crucial for the provision of equitable and fast treatment. Evidence indicates sex differences in prevalence and types of non-traditional stroke symptoms or signs, prevalence of stroke mimics, and door-to-imaging times, but no substantial differences in use of emergency medical services, stroke knowledge, eligibility for or access to thrombolysis or thrombectomy, or outcomes after either therapy. Women presenting with stroke mimics or non-traditional stroke symptoms can be misdiagnosed, which can lead to inappropriate triage, and acute treatment delays. It is essential for health-care providers to recognise possible sex differences in stroke symptoms, signs, and mimics. Future studies focused on confounders that affect treatment and outcomes, such as age and pre-stroke function, are also needed.

AB - With the greater availability of treatments for acute ischaemic stroke, including advances in endovascular therapy, personalised assessment of patients before treatment is more important than ever. Women have a higher lifetime risk of stroke; therefore, reducing potential sex differences in the acute stroke setting is crucial for the provision of equitable and fast treatment. Evidence indicates sex differences in prevalence and types of non-traditional stroke symptoms or signs, prevalence of stroke mimics, and door-to-imaging times, but no substantial differences in use of emergency medical services, stroke knowledge, eligibility for or access to thrombolysis or thrombectomy, or outcomes after either therapy. Women presenting with stroke mimics or non-traditional stroke symptoms can be misdiagnosed, which can lead to inappropriate triage, and acute treatment delays. It is essential for health-care providers to recognise possible sex differences in stroke symptoms, signs, and mimics. Future studies focused on confounders that affect treatment and outcomes, such as age and pre-stroke function, are also needed.

UR - http://www.scopus.com/inward/record.url?scp=85048714425&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85048714425&partnerID=8YFLogxK

U2 - 10.1016/S1474-4422(18)30201-1

DO - 10.1016/S1474-4422(18)30201-1

M3 - Review article

VL - 17

SP - 641

EP - 650

JO - The Lancet Neurology

JF - The Lancet Neurology

SN - 1474-4422

IS - 7

ER -